Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011

Journal of the American Medical Directors Association

Volumn 16, Issue 10, 2015, Pages 898.e9-898.e14

  Lee, Sei J ^a   Stijacic Cenzer, Irena ^a   Barnhart, Caroline ^a   McClymont, Keelan ^a   Steinman, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes; Glucose lowering; Insulin; Metformin; Nursing home

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; AMYLIN DERIVATIVE; ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLIBENCLAMIDE; GLIPIZIDE; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN GLARGINE; ISOPHANE INSULIN; MEGLITINIDE; METFORMIN; PIG INSULIN; 2,4-THIAZOLIDINEDIONE; SULFONYLUREA DERIVATIVE;

AGED; ARTICLE; COHORT ANALYSIS; DIABETES MELLITUS; DRUG USE; EXPLORATORY RESEARCH; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING HOME PATIENT; PRESCRIPTION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; VERY ELDERLY; VETERANS HEALTH; CLINICAL PRACTICE; DRUG UTILIZATION; GOVERNMENT; NURSING HOME; TRENDS; UNITED STATES;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS; DRUG UTILIZATION; FEMALE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; NURSING HOMES; PRACTICE PATTERNS, PHYSICIANS'; RETROSPECTIVE STUDIES; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84944150365     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2015.06.020     Document Type: Article

References (37)

1. Zhang X., Decker F.H., Luo H., et al. Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995-2004. J Am Geriatr Soc 2010, 58:724-730.
2. Resnick H.E., Heineman J., Stone R., Shorr R.I. Diabetes in U.S. nursing homes, 2004. Diabetes Care 2008, 31:287-288.
3. Boyle J.P., Thompson T.J., Gregg E.W., et al. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010, 8:29.
4. Huang E.S., Laiteerapong N., Liu J.Y., et al. Rates of complications and mortality in older patients with diabetes mellitus: The diabetes and aging study. JAMA Intern Med 2014, 174:251-258.
5. Zarowitz B.J., Tangalos E.G., Hollenack K., O'Shea T. The application of evidence-based principles of care in older persons (issue 3): Management of diabetes mellitus. J Am Med Dir Assoc 2006, 7:234-240.
6. Feldman S.M., Rosen R., DeStasio J. Status of diabetes management in the nursing home setting in 2008: A retrospective chart review and epidemiology study of diabetic nursing home residents and nursing home initiatives in diabetes management. J Am Med Dir Assoc 2009, 10:354-360.
7. Standards of medical care in diabetes-2007. Diabetes Care 2007, 30:S4-S41. American Diabetes Association.
8. Woodcock J., Sharfstein J.M., Hamburg M. Regulatory action on rosiglitazone by the U.S. Food and Drug Administration. N Engl J Med 2010, 363:1489-1491.
9. Nissen S.E., Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007, 356:2457-2471.
10. Tanne J.H. FDA places "black box" warning on antidiabetes drugs. BMJ 2007, 334:1237.
11. Gerstein H.C., Miller M.E., Byington R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. Action to Control Cardiovascular Risk in Diabetes Study Group.
12. Lee S.J., Eng C. Goals of glycemic control in frail older patients with diabetes. JAMA 2011, 305:1350-1351.
13. Inzucchi S.E., Bergenstal R.M., Buse J.B., et al. Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012, 35:1364-1379.
14. Kirkman M.S., Briscoe V.J., Clark N., et al. Diabetes in older adults. Diabetes Care 2012, 35:2650-2664.
15. Standards of medical care in diabetes-2014. Diabetes Care 2014, 37:S14-S80. American Diabetes Association.
16. Smith M.W., Joseph G.J. Pharmacy data in the VA health care system. Med Care Res Rev 2003, 60:92S-123S.
17. Dellefield M.E. The work of the RN Minimum Data Set coordinator in its organizational context. Res Gerontol Nurs 2008, 1:42-51.
18. Schafer J.L. Multiple imputation: A primer. Stat Methods Med Res 1999, 8:3-15.
19. White I.R., Royston P., Wood A.M. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011, 30:377-399.
20. Morris J.N., Fries B.E., Morris S.A. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci 1999, 54:M546-M553.
21. Kurella Tamura M., Covinsky K.E., Chertow G.M., et al. Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 2009, 361:1539-1547.
22. Desai N.R., Shrank W.H., Fischer M.A., et al. Patterns of medication initiation in newly diagnosed diabetes mellitus: Quality and cost implications. Am J Med 2012, 125:302.e1-302.e7.
23. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012, 60:616-631. American Geriatrics Society Beers Criteria Update Expert Panel.
24. van Staa T., Abenhaim L., Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997, 50:735-741.
25. Shorr R.I., Ray W.A., Daugherty J.R., Griffin M.R. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996, 44:751-755.
26. Nathan D.M., Buse J.B., Davidson M.B., et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006, 29:1963-1972.
27. Nathan D.M., Buse J.B., Davidson M.B., et al. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32:193-203.
28. Aspinall S.L., Zhao X., Good C.B., et al. Intervention to decrease glyburide use in elderly patients with renal insufficiency. Am J Geriatr Pharmacother 2011, 9:58-68.
29. Miller M., Knatterud G.L., Hawkins B.S., Newberry W.B. A study of the effects of hypoglycemia agents on vascular complications in patients with adult-onset diabetes. VI. Supplementary report on nonfatal events in patients treated with tolbutamide. Diabetes 1976, 25:1129-1153.
30. Garratt K.N., Brady P.A., Hassinger N.L., et al. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 1999, 33:119-124.
31. Simpson S.H., Majumdar S.R., Tsuyuki R.T., et al. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: A population-based cohort study. CMAJ 2006, 174:169-174.
32. Schramm T.K., Gislason G.H., Vaag A., et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study. Eur Heart J 2011, 32:1900-1908.
33. Garber A.J., Abrahamson M.J., Barzilay J.I., et al. American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement-executive summary. Endocr Pract 2013, 19:536-557.
34. Gionfriddo M.R., McCoy R.G., Lipska K.J. The 2013 American Association of Clinical Endocrinologists' diabetes mellitus management recommendations: Improvements needed. JAMA Intern Med 2014, 174:179-180.
35. Hayward R.A., Kent D.M. 6 EZ steps to improving your performance: (or how to make P4P pay 4U!). JAMA 2008, 300:255-256.
36. Li C., Ford E.S., Zhao G., et al. Trends of insulin use among US adults with type 2 diabetes: The Behavioral Risk Factor Surveillance System, 1995-2007. J Diabet Complications 2012, 26:17-22.
37. Age-Adjusted Percentage of Adults with Diabetes Using Diabetes Medication, by Type of Medication, United States, 1997-2011. Nov 19, 2013. Available at:. Accessed June 24, 2015. http://www.cdc.gov/diabetes/statistics/meduse/fig2.htm.